Cannabis and the treatment of dementia
Last updated: July 20, 2018
Summary: While there is ongoing promising research on the effects of cannabis, there is currently no evidence that cannabis is useful for the treatment or prevention of Alzheimer’s disease.
Limbic-predominant aged-related TDP-43 encephalopathy (LATE-NC)
Last updated: May 2, 2019
Summary: The discovery of LATE-NC speaks to the growing umbrella of different dementias and the complexity of these diseases. The Alzheimer Society is hopeful that these new findings will pave the way to new treatments that target different forms of dementia.
Meaningful engagement of people living with dementia
Last updated: August 17, 2018
Summary: The Alzheimer Society of Canada believes that people with dementia want to inform the work that directly impacts their quality of life and well-being.
The Society recognizes the right of people with dementia to be actively involved in the work of organizations that represent their interests and value their involvement.
Medical assistance in dying (MAiD) for people living with dementia
Last updated: October 15, 2019
Summary: The Alzheimer Society respects the rights of all persons with dementia to advocate for their individual best interests, including advocating for access to MAiD through advance requests.
The Alzheimer Society provides Canadians living with dementia the support and information they need to make informed decisions about their care, including at the end of life. The Society will continue to inform persons with dementia about the legislative processes related to MAiD and any changes to the law.
We encourage those interested in this issue to read the Council of Canadian Academies’ report on medical assistance in dying.
Online self-assessments for Alzheimer’s disease and other dementias
Last updated: May 26, 2014
Summary: Alzheimer’s disease and other dementias are complex diseases of the brain and qualified health care providers should be involved in diagnosing these conditions. People who are experiencing memory issues accompanied by difficulties in day-to-day activities and skills should contact their healthcare provider.
Race and dementia in Canada
Last updated: October 5, 2020
Summary: At the Alzheimer Society of Canada, we work to change the lives of those living with dementia. However, we need to do more to combat systemic oppression.
Use of antipsychotic medications to treat people living with dementia in long-term care homes
Statement summary: The Alzheimer Society recommends that antipsychotics only be used as a last resort to treat behavioural and psychological symptoms of dementia, especially in older adults. The Society encourages health professionals in all settings to practice a person-centred approach to care for people living with dementia.